NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/31/2023
Back to search
Official data from USPTO
OPEXTAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
05/31/2023
Trademark type
Combined
Nice classes
3, 5
Filing date
07/03/2014
Registration date
04/07/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/26/2021
Last transaction
11/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
IT
Examiner
STEIN, JAMES
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "OPEXTAN" in stylized print, with one of the strokes of the letter "x" extending diagonally to the right above "tan", above a design of a circle within a larger shaded circle forming a stylized representation of an olive that is above and to the right of the letter "n", with the extended diagonal line from the letter "x" getting thicker as it descends to the right of the stylized olive and forming a single curved line.
Holders and representatives
Holders
INDENA S.p.A.
Representatives
Bianchetti Bracco Minoja S.r.l.
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Plant and herb extracts sold as components of cosmetics
Class 5
Medicinal plant extracts for pharmaceutical and medical usefor the treatment of cardiovascular system diseasesgastroenteric system diseasesrespiratory system diseasesimmune and endocrine system diseases and for the treatment of viral diseases
Publications
History of USPTO decisions and trademark events.
44 publications found
FINP
FINAL DECISION TRANSACTION PROCESSED BY IB
05/22/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/15/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
03/20/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
03/20/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
03/20/2023
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/26/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/04/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/20/2022
RFNT
REFUSAL PROCESSED BY IB
12/12/2021
C71T
CANCELLED SECTION 71
11/26/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/29/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/22/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
02/01/2018
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
10/02/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/14/2015
FIMP
FINAL DISPOSITION PROCESSED
08/14/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2015
GPNX
NOTIFICATION PROCESSED BY IB
02/06/2015
PUBO
PUBLISHED FOR OPPOSITION
01/20/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/31/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/31/2014
NPUB
NOTICE OF PUBLICATION
12/31/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/16/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/12/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/12/2014
ALIE
ASSIGNED TO LIE
12/12/2014
RFNT
REFUSAL PROCESSED BY IB
12/12/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/12/2014
RFRR
REFUSAL PROCESSED BY MPU
11/12/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/07/2014
MAFR
APPLICATION FILING RECEIPT MAILED
11/07/2014
CNRT
NON-FINAL ACTION WRITTEN
11/06/2014
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
11/06/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/04/2014
CNRT
NON-FINAL ACTION WRITTEN
11/03/2014
DOCK
ASSIGNED TO EXAMINER
11/03/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/03/2014
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/24/2014
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/23/2014
Continuous trademark protection
Get notified about every new filing that threatens OPEXTAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.